A stem cell transplant was found to be better than Lemtrada (alemtuzumab) for lowering disease activity and slowing disability worsening in people with highly active relapsing forms of multiple sclerosis (MS), a small study in Lithuania showed.
While both treatments were similarly effective in the first couple of years, patients given the transplant began to see disability improvements later on; in turn, disability showed signs of accumulating in those who received Lemtrada.
“Given these findings, clinical trials evaluating efficacy of [stem cell transplant] in severe disability in MS patients should be considered,” the researchers wrote.
https://multiplesclerosisnewstoday.c...eatment-study/
While both treatments were similarly effective in the first couple of years, patients given the transplant began to see disability improvements later on; in turn, disability showed signs of accumulating in those who received Lemtrada.
“Given these findings, clinical trials evaluating efficacy of [stem cell transplant] in severe disability in MS patients should be considered,” the researchers wrote.
https://multiplesclerosisnewstoday.c...eatment-study/